MAPT and Alzheimer disease: The characteristic histopathological hallmark of AD is the extraneuronal aggregation of amyloid-β (Aβ) peptide fragments into plaques, along with intraneuronal abnormal tau protein accumulation, which both serve as AD biomarkers (Long and Holtzman, 2019).